Get started
Author

Inês Q Dunões

Observed names: I. Dunoes, I.Q. Dunões, Inês Dunões
ORCID: 0009-0001-0434-2513
Observed ORCID: 0009-0001-0434-2513
OpenAlex ID: A5040490761
Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing
2025 · Lisa Gonçalves, Helena Guedes, et al. · Cancers · 7
1872P Pain in oncology: Prevalence and characterization
2020 · R. Cunha, A.G. da Silva Oliveira, et al. · Annals of Oncology · 5
Epithelioid hemangioendothelioma: Real-world data about a rare entity in a Portuguese tertiary cancer center.
2024 · Sara Cabral, Rita Freitas, et al. · Journal of Clinical Oncology · 2
A Complete Response to Pembrolizumab in Malignant Peritoneal Mesothelioma: A Case Report
2024 · Maria Bairos Menezes, Rita Pedroso de Lima, et al. · Cureus · 2
PDF
P245 Avelumab in advanced urothelial carcinoma: Insights from a multicenter portuguese study on efficacy, safety, and treatment sequencing
2024 · L. Goncalves, H. Guedes, et al. · European Urology Open Science · 1
Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals
2026 · Rita Freitas, Tiago Barroso, et al. · Cureus
Information Perception and Unmet Needs in Cancer Patients Beginning Systemic Therapy: Needs for Patient Education
2026 · Inês Dunões, Paulo Infante, et al. · Journal of Cancer Education
Solitary Brain Lesion: An Unexpected Presentation of Urachal Adenocarcinoma
2025 · Inês Q Dunões, Maria Baió, et al. · Cureus
PDF
Primary Thromboprophylaxis and onkoTEV Score in Pancreatic Cancer: Real-World Evidence from a Portuguese Cohort
2025 · Inês Dunões, Inês Bastos, et al. · Thrombosis and Haemostasis
Abstract P5-01-12: Subsequent Treatments After Progression On Cyclin-Dependent Kinase 4/6 Inhibitors - A Multicentric Portuguese Real-world Data Study
2025 · Ana Rita Rego Freitas, Inês F. Eiriz, et al. · Clinical Cancer Research
105P Subsequent treatments after progression on cyclin-dependent kinase 4/6 inhibitors: A multicentric real-world data study
2024 · A.R.R. Freitas, I.F. Eiriz, et al. · ESMO Open
235 Nasopharyngeal cancer chemotherapy – before or after curative chemoradiation?
2024 · Sara Magno, Rita Freitas, et al. · Radiotherapy and Oncology
Predictive factors for relapse in triple-negative breast cancer after neoadjuvant chemotherapy: real-world data from a Portuguese hospital
2024 · Maria Bairos Menezes, Rita Pedroso De Lima, et al. · European Journal of Surgical Oncology
Real world data from Avelumab in Advanced or Metastatic Urothelial Carcinoma
2023 · L. Goncalves, J. Gramaça, et al. · European Urology Open Science
1122P Neutrophil/lymphocyte ratio and systemic inflammatory index as prognostic biomarkers in metastatic melanoma patients under immune checkpoint inhibitors: Could any of them be used?
2023 · M.B. Menezes, L. Goncalves, et al. · Annals of Oncology
PDF
P-295 Retrospective cohort study of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer: A real-world data from 4 hospitals in Portugal
2023 · M. Menezes, J. Araújo, et al. · Annals of Oncology
PDF
178P Imaging for distant metastasis in local and locally advanced breast cancer: Practice and detection rates
2021 · A.G. Da Silva Oliveira, M. Menezes, et al. · Annals of Oncology
P-83 Pancreatic cancer, treatment options, and sequential therapy: The experience of a district oncology center
2020 · A. Oliveira, M. Menezes, et al. · Annals of Oncology
PDF
P-84 Colon cancer in the elderly: A comprehensive assessment of treatment and its outcomes
2020 · A. Oliveira, M. Menezes, et al. · Annals of Oncology
Works count: 19
Citation count: 17
H-index: 2
I10-index:
Year
Topic
Type